Bupropion XR 150 Adco 150 mg. Extended-release tablets.
PDF Leaflet Revision Date: 07 June 2023
Clinical Summary
Quick overview from the medicine insert
Indication
Treatment of depression.
Dosage (summary)
Initial: 150 mg once daily; may increase to 300 mg once daily.
Special Populations
- Elderly
- Renal impairment
- Hepatic impairment
Pregnancy & Breastfeeding
Not established; potential risk of congenital malformations. Avoid breastfeeding.
Key Drug Interactions
- MAOIs
- CYP2D6 substrates
- Alcohol
Contraindications
- Under 18 years
- Seizure disorder
- Hypersensitivity
- Bulimia or anorexia
- Severe hepatic cirrhosis
Common side effects
- Insomnia
- Dry mouth
- Headache
- Increased blood pressure
Counselling Points
- Swallow tablets whole.
- Monitor for worsening depression or suicidal thoughts.
- Avoid alcohol.
Serious warnings
- Risk of seizures
- Suicidal ideation
- Caution in cardiovascular disease
Important Disclaimer
The Bupropion XR 150 Adco 150 mg. Extended-release tablets. professional information leaflet below is the property of Adcock Ingram and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
